Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.
about
Editorial: Cell Stress, Metabolic Reprogramming, and Cancer.Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy.The -Antioxidant Response Element Signaling Pathway Controls Fibrosis and Autoimmunity in SclerodermaThe Immunometabolomic Interface Receptor Hydroxycarboxylic Acid Receptor 2 Mediates the Therapeutic Effects of Dimethyl Fumarate in Autoantibody-Induced Skin Inflammation
P2860
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.
@en
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.
@nl
type
label
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.
@en
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.
@nl
prefLabel
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.
@en
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.
@nl
P2093
P2860
P50
P356
P1433
P1476
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.
@en
P2093
Adele M Snowman
Nagireddy Putluri
Paul M Kim
Vasanta Putluri
P2860
P304
P356
10.1126/SCIENCE.AAN4665
P407
P577
2018-03-29T00:00:00Z